Medtronic plc (MDT) Risk Factors
Health CareLatest 10-K filed Jun 18, 2026Source: SEC EDGAR
WealthWire extracted and classified 37 risk factors from Medtronic plc’s latest SEC filing, mapping each to a standardized risk taxonomy so they can be compared across every company and sector. The breakdown below shows how those disclosures distribute across risk categories.
Financial
9 factorsLegal & regulatory
8 factorsMarket & business
6 factorsESG & reputation
4 factorsOperations & people
4 factorsHealthcare & life sciences
3 factorsTechnology
2 factorsOther
1 factorsRecent key developments
Concrete developments — dated events, named agreements and instruments, legal proceedings — that Medtronic plc surfaced in its latest filing.
- Ongoing separation of the Diabetes Business from the Company, with MiniMed's March 2026 IPO retaining approximately 90% ownership.March 2026
- Ireland enacted legislation implementing OECD Pillar Two Model Rules (global minimum tax of 15%), effective for Medtronic in fiscal year 2025.2025
- Medtronic, Inc.'s U.S. tax litigation: IRS audit report issued in March 2009 for fiscal years 2005 and 2006; unresolved issue relates to income allocation between Medtronic, Inc. and its Puerto Rico subsidiary; Tax Court opinion in August 2022; IRS appeal to Eighth Circuit in September 2023; Medtronic cross-appeal in October 2023; Appellate Court remanded case to Tax Court in September 2025.September 2025
- EU Medical Device Regulation implementation deadlines extended to end of 2027 for high-risk devices and end of 2028 for medium- and low-risk devices.2028
- 2025 Annual General Meeting authorization limits share issuance to 20% of issued ordinary shares and disapplies preemption rights, expiring April 16, 2027.April 16, 2027
Go deeper on MDT
This page shows the category breakdown of the latest filing. The WealthWire API and dashboard add the full risk-factor text, multi-year trends, sector comparisons, and CSV export — for MDT and every other S&P 500 company.